Jianmin Pharmaceutical Group Co Ltd (600976) — Strategic Asset Allocation Index
Jianmin Pharmaceutical Group Co Ltd (600976) has a Strategic Asset Allocation Index of 21.8% as of June 2023. Strategic assets (PP&E of CN¥430.27 Million plus long-term investments of CN¥-) total CN¥430.27 Million, measured against net assets of CN¥1.98 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Jianmin Pharmaceutical Group Co Ltd Strategic Asset Allocation Index (2001–2022)
This chart shows how Jianmin Pharmaceutical Group Co Ltd's Strategic Asset Allocation Index has evolved across 22 annual periods from 2001 to 2022. As of June 2023, the index stands at 21.8%, representing strategic assets of CN¥430.27 Million against net assets of CN¥1.98 Billion CNY. Explore how efficiently does Jianmin Pharmaceutical Group Co Ltd generate cash to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Jianmin Pharmaceutical Group Co Ltd (2001–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Jianmin Pharmaceutical Group Co Ltd from 2001 to 2022, covering 22 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see market cap of Jianmin Pharmaceutical Group Co Ltd.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 22.4% | CN¥417.65 Million | CN¥417.65 Million | CN¥- | CN¥1.87 Billion | ▼ -2.9 pp |
| 2021 | 25.3% | CN¥396.65 Million | CN¥396.65 Million | CN¥- | CN¥1.57 Billion | ▼ -2.8 pp |
| 2020 | 28.1% | CN¥371.76 Million | CN¥371.76 Million | CN¥- | CN¥1.32 Billion | ▲ +0.5 pp |
| 2019 | 27.5% | CN¥332.75 Million | CN¥332.75 Million | CN¥- | CN¥1.21 Billion | ▼ -16.4 pp |
| 2018 | 44.0% | CN¥503.49 Million | CN¥273.29 Million | CN¥230.21 Million | CN¥1.15 Billion | ▲ +4.1 pp |
| 2017 | 39.9% | CN¥441.74 Million | CN¥245.55 Million | CN¥196.20 Million | CN¥1.11 Billion | ▲ +2.6 pp |
| 2016 | 37.3% | CN¥385.06 Million | CN¥239.69 Million | CN¥145.37 Million | CN¥1.03 Billion | ▲ +5.5 pp |
| 2015 | 31.9% | CN¥317.77 Million | CN¥231.26 Million | CN¥86.52 Million | CN¥997.36 Million | ▲ +9.2 pp |
| 2014 | 22.7% | CN¥227.30 Million | CN¥227.30 Million | CN¥- | CN¥1.00 Billion | ▼ -3.5 pp |
| 2013 | 26.2% | CN¥246.28 Million | CN¥246.28 Million | CN¥- | CN¥940.46 Million | ▼ -0.8 pp |
| 2012 | 27.0% | CN¥243.63 Million | CN¥243.63 Million | CN¥- | CN¥903.10 Million | ▼ -1.3 pp |
| 2011 | 28.3% | CN¥248.16 Million | CN¥248.16 Million | CN¥- | CN¥876.97 Million | ▼ -2.1 pp |
| 2010 | 30.4% | CN¥257.62 Million | CN¥257.62 Million | CN¥- | CN¥848.81 Million | ▼ -6.1 pp |
| 2009 | 36.5% | CN¥299.31 Million | CN¥299.31 Million | CN¥- | CN¥820.32 Million | ▲ +1.1 pp |
| 2008 | 35.4% | CN¥269.71 Million | CN¥269.71 Million | CN¥- | CN¥761.24 Million | ▲ +0.9 pp |
| 2007 | 34.5% | CN¥256.19 Million | CN¥256.19 Million | CN¥- | CN¥742.63 Million | ▼ -6.0 pp |
| 2006 | 40.5% | CN¥310.60 Million | CN¥310.60 Million | CN¥- | CN¥766.61 Million | ▼ -2.6 pp |
| 2005 | 43.2% | CN¥327.88 Million | CN¥327.88 Million | CN¥- | CN¥759.65 Million | ▲ +1.0 pp |
| 2004 | 42.2% | CN¥297.60 Million | CN¥297.60 Million | CN¥- | CN¥705.12 Million | ▼ -38.9 pp |
| 2003 | 81.1% | CN¥235.38 Million | CN¥235.38 Million | CN¥- | CN¥290.32 Million | ▲ +21.4 pp |
| 2002 | 59.6% | CN¥155.38 Million | CN¥155.38 Million | CN¥- | CN¥260.54 Million | ▲ +8.6 pp |
| 2001 | 51.0% | CN¥119.21 Million | CN¥119.21 Million | CN¥- | CN¥233.57 Million | — |